Skip to contentSkip to Braille Studio

Library / Laws / 116th Congress / Senate Bills / S. 1224

S. 1224

To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2019-04-295.8K⠃⠗⠋
Reported in Senate2019-06-2811.8K⠃⠗⠋